Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha S Thomas

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2020
Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer ResponseFangwen Zou, Hamzah Abu-Sbeih, Weijie Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2021
Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With CancerJake S Jacob, Barbara E Dutra, Victor Garcia-Rodriguez, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2023
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitorsGabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of Cancer Research and Clinical Oncology|October 15, 2022
Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignanciesAustin R Thomas, Mostafa Eyada, Miho Kono, et al.
Journal for Immunotherapy of Cancer|June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitisYousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
Cancers|January 23, 2024
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care CenterMalek Shatila, Farzin Eshaghi, Austin R Thomas, et al.
Targeted Oncology|December 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer ImmunotherapyCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Annals of Gastroenterology|March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitisCarolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Science Translational Medicine|June 14, 2023
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitisTaylor M Halsey, Anusha S Thomas, Tomo Hayase, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2020
Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer ResponseFangwen Zou, Hamzah Abu-Sbeih, Weijie Ma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2021
Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With CancerJake S Jacob, Barbara E Dutra, Victor Garcia-Rodriguez, et al.
Journal of Cancer Research and Clinical Oncology|November 2, 2023
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitorsGabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of Cancer Research and Clinical Oncology|October 15, 2022
Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignanciesAustin R Thomas, Mostafa Eyada, Miho Kono, et al.
Journal for Immunotherapy of Cancer|June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitisYousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
Cancers|January 23, 2024
Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care CenterMalek Shatila, Farzin Eshaghi, Austin R Thomas, et al.
Targeted Oncology|December 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer ImmunotherapyCarolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali, et al.
Annals of Gastroenterology|March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitisCarolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Science Translational Medicine|June 14, 2023
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitisTaylor M Halsey, Anusha S Thomas, Tomo Hayase, et al.
Pageof 5